RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @unibirm_MDS: #COVID19 | Led by Professor Jon Deeks (@deeksj), scientists have analysed worldwide data to examine the accuracy of #antib…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
Love the tweet review. You can hear Jon’s audio version this week on BMJ Talk Evidence https://t.co/J5XhYVQSeH. We need to improve the science but we also need to define what questions we want this evidence to answer
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
@Elaventi Dazugehörige Studie : https://t.co/KaAYtFbu4b
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
Thank you, @deeksj! Great ressource @PuhanMilo @nicolamlow
Also love that Cochrane do plain language versions.
RT @GrimshawJeremy: Excellent work by @deeksj and colleagues for @cochranecollab! Antibody tests for identification of current and past inf…
RT @tlassers: #CochraneEvidence in diagnosis of #COVID19. What we know now & what we need to know from a surging evidence base
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
@cricketwyvern Not sure if you have seen this thread below about Antibody Tests
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @JochenCals: Topdraad over vandaag gepubliceerde Cochrane over #COVID19 antistoffen testen. Goede specificiteit, matige sensitiviteit. G…
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @GrimshawJeremy: Excellent work by @deeksj and colleagues for @cochranecollab! Antibody tests for identification of current and past inf…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @SouthAfricanASP: “Antibody tests likely to have role in detecting previous SARS‐CoV‐2 if used >15 days after symptom onset. Duration Ab…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @dnunan79: Cochrane review in 2 months anyone?! This is going to cause no end of trouble when it comes to the FTE section of future fun…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
@DrPieterPeach This was a useful thread. https://t.co/btOVYYKKSy
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @Richard_D_Riley: "Antibody tests for identification of current and past infection with SARS‐CoV‐2" - https://t.co/4rRIYDA4wW - congrat…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @SouthAfricanASP: “Antibody tests likely to have role in detecting previous SARS‐CoV‐2 if used >15 days after symptom onset. Duration Ab…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
Great info here on Antibody tests for SARS-Cov-2 @CleophasChimbe2 @tinamudzviti @zcphp @MoHCCZim @jmanasa @SolomonMukwenha @ZAMLCS1
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
“Antibody tests likely to have role in detecting previous SARS‐CoV‐2 if used >15 days after symptom onset. Duration Ab rise currently unknown - very little data beyond 35 days post‐symptom onset. Uncertain utility for seroprevalence surveys for pub heal
RT @ccaneloa: . @cochranecollab SR of #COVIDー19 sensitivity of IgG/IgM testing depends on # of days post-onset of symptoms: -30.1% (95% CI…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @CochraneSweden: Väldigt aktuell kunskapsöversikt om testning av antikroppar för pågående eller tidigare SARS-CoV-2 smitta. Spännande fö…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @ccaneloa: . @cochranecollab SR of #COVIDー19 sensitivity of IgG/IgM testing depends on # of days post-onset of symptoms: -30.1% (95% CI…
RT @GrimshawJeremy: Excellent work by @deeksj and colleagues for @cochranecollab! Antibody tests for identification of current and past inf…
RT @chrishendel: Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with…
RT @chrishendel: Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with…
RT @GSCollins: Two #covid19 reviews one on diagnostic & prognostic prediction models (https://t.co/2bp1HHDDUc) and this new one on diagnost…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @tlassers: #CochraneEvidence in diagnosis of #COVID19. What we know now & what we need to know from a surging evidence base
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @tlassers: Test timing best in testing times? #COVID19 antibody test accuracy assessed in new @CochraneLibrary review https://t.co/qsrJ…
RT @chrishendel: Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
Re: antibody tests- “we don’t have much data [on the tests] and we can’t trust any of it.” @bmj_latest
RT @Richard_D_Riley: "Antibody tests for identification of current and past infection with SARS‐CoV‐2" - https://t.co/4rRIYDA4wW - congrat…
Los test serológicos de covid-19 tienen una precisión global superior al 90% en pacientes hospitalizados Una nueva revisión Cochrane ha analizado 54 estudios relevantes sobre la precisión de 25 test serológicos de los casi 300 que hay en el mercado https
RT @giordanopg: Nueva revisión Cochrane que resalta lo bueno y lo incierto de las pruebas de anticuerpos: https://t.co/UgGzq1PWUe
RT @chrishendel: Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with…
Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with the #COVID19 virus? https://t.co/t2A45pazUs #antibodytesting #covid19vt #covid_19 #COVID19Pandemic https://t.co/1YvES3jzEd
Great work and great thread. Worth the read
Antibodies tests, not looking good so far.
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…